# West Pharmaceutical Services, Inc. (WST)

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $3.07B | $1.10B | $585M | $494M | $6.79 |
| 2024 | $2.89B | $999M | $570M | $493M | $6.69 |
| 2023 | $2.95B | $1.13B | $676M | $593M | $7.88 |
| 2022 | $2.89B | $1.14B | $734M | $586M | $7.73 |
| 2021 | $2.83B | $1.18B | $752M | $662M | $8.67 |
| 2020 | $2.15B | $768M | $407M | $346M | $4.57 |
| 2019 | $1.84B | $606M | $297M | $242M | $3.21 |
| 2018 | $1.72B | $545M | $240M | $207M | $2.74 |
| 2017 | $1.60B | $513M | $226M | — | $1.99 |
| 2016 | $1.51B | $501M | $195M | — | $1.91 |
| 2015 | $1.40B | $456M | $129M | — | $1.30 |
| 2014 | $1.42B | $448M | $182M | — | $1.75 |
| 2013 | $1.37B | $435M | $162M | — | $1.57 |
| 2012 | $1.27B | $388M | $135M | — | $1.15 |
| 2011 | $1.19B | $339M | $110M | — | $1.08 |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $4.27B | $1.09B | $3.18B | $791M | $203M |
| 2024 | $3.64B | $961M | $2.68B | $485M | $203M |
| 2023 | $3.83B | $949M | $2.88B | $854M | $207M |
| 2022 | $3.62B | $932M | $2.68B | $894M | $209M |
| 2021 | $3.31B | $978M | $2.34B | $763M | $253M |
| 2020 | $2.79B | $939M | $1.85B | $616M | $255M |
| 2019 | $2.34B | $768M | $1.57B | $439M | $257M |
| 2018 | $1.98B | $583M | $1.40B | $337M | $196M |
| 2017 | $1.86B | $583M | $1.28B | $236M | $197M |
| 2016 | $1.72B | $599M | $1.12B | $203M | $229M |
| 2015 | $1.70B | $671M | $1.02B | $275M | $298M |
| 2014 | $1.67B | $713M | $957M | $255M | $336M |
| 2013 | $1.67B | $765M | $906M | $230M | $374M |
| 2012 | $1.56B | $835M | $729M | $162M | $412M |
| 2011 | $1.40B | $744M | $655M | $92M | $349M |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $755M | $286M | $469M |
| 2024 | $653M | $377M | $276M |
| 2023 | $777M | $362M | $415M |
| 2022 | $724M | $285M | $439M |
| 2021 | $584M | $253M | $331M |
| 2020 | $473M | $174M | $298M |
| 2019 | $367M | $126M | $241M |
| 2018 | $289M | $105M | $184M |
| 2017 | $263M | $131M | $133M |
| 2016 | $219M | $170M | $49M |
| 2015 | $212M | $132M | $81M |
| 2014 | $183M | $112M | $71M |
| 2013 | $221M | $152M | $69M |
| 2012 | $187M | $131M | $56M |
| 2011 | $131M | $95M | $35M |

Source: [CompaniesByCap](https://companiesbycap.com/company/WST)